Showing results (561-570 of 3,470) with videos related to
Sort By:
Pageof 347
Clinical Pharmacokinetics|September 12, 2008
Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patientsBenoit Blanchet, Vincent Jullien, Christophe Vinsonneau, et al.Clinical Pharmacokinetics|September 12, 2008
Towards quantitative prediction of oral drug absorptionJennifer B Dressman, Kirstin Thelen, Ekarat JantratidClinical Pharmacokinetics|August 27, 2009
Pharmacokinetic and pharmacodynamic parameters of antimicrobials: potential for providing dosing regimens that are less vulnerable to resistanceChiara Adembri, Andrea NovelliClinical Pharmacokinetics|December 17, 2008
Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviourAnna-Britta Lind, Margareta Reis, Finn Bengtsson, et al.Clinical Pharmacokinetics|November 1, 1991
Bioinequivalence of four 100 mg oral aspirin formulations in healthy volunteersF Bochner, A A Somogyi, K M WilsonClinical Pharmacokinetics|September 4, 2009
Clinical pharmacokinetics and pharmacodynamics of tigecyclineApril Barbour, Stephan Schmidt, Benjamin Ma, et al.Clinical Pharmacokinetics|April 1, 1991
An updated comparison of drug dosing methods. Part II: TheophyllineS M Erdman, K A Rodvold, R D PrykaClinical Pharmacokinetics|November 26, 2008
Does oxcarbazepine warrant therapeutic drug monitoring? A critical reviewPenny Bring, Mary H H EnsomClinical Pharmacokinetics|November 26, 2008
Pharmacokinetics of sapropterin in patients with phenylketonuriaFrançois Feillet, Lorne Clarke, Concetta Meli, et al.Clinical Pharmacokinetics|August 27, 2005
Microdialysis: current applications in clinical pharmacokinetic studies and its potential role in the futureChristian Joukhadar, Markus MüllerPageof 347